Skip to main content

Georgia Marie Beasley, MD, MHS

Assistant Program Director, Complex General Surgical Oncology Fellowship
Associate Professor of Surgery
Office: Dept of Surgery, Durham, NC 27710
Campus Mail: DUMC Erwin Rd, Durham, NC 27710

Education and Training

  • Surgical Oncology Fellow, Surgery, Ohio State University, 2015 - 2017
  • General Surgery Resident, Surgery, Duke University, 2008 - 2015
  • M.H.S., Duke University, 2012
  • M.D., Duke University School of Medicine, 2008
  • B.A., Duke University, 2001

Publications

Dikshit, Anushka, Junqi Lu, Amy E. Ford, Simone Degan, Yingai J. Jin, Huiying Sun, Amanda Nichols, et al. “Potential Utility of Synthetic D-Lactate Polymers in Skin Cancer.” Jid Innovations 1, no. 3 (September 2021): 100043–100043. https://doi.org/10.1016/j.xjidi.2021.100043.

Full Text

Sarver, Melissa, Michael C. Brown, Kristen E. Rhodin, April K. S. Salama, and Georgia M. Beasley. “Predictive factors of neoadjuvant immune checkpoint blockade in melanoma.” Hum Vaccin Immunother, July 13, 2021, 1–9. https://doi.org/10.1080/21645515.2021.1943987.

Full Text

Broman, Kristy Kummerow, Tasha Hughes, Lesly Dossett, James Sun, Dennis Kirichenko, Michael J. Carr, Avinash Sharma, et al. “Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).” Cancer 127, no. 13 (July 1, 2021): 2251–61. https://doi.org/10.1002/cncr.33483.

Full Text

Straker, Richard J., Yun Song, James Sun, Adrienne B. Shannon, Leah S. Cohen, Elnara Muradova, Hala Daou, et al. “Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era.” Ann Surg Oncol 28, no. 7 (July 2021): 3512–21. https://doi.org/10.1245/s10434-020-09384-8.

Full Text

Farrow, Norma E., and Georgia M. Beasley. “ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma.” Annals of Surgical Oncology 28, no. 7 (July 2021): 3511. https://doi.org/10.1245/s10434-021-09595-7.

Full Text

Farrow, Norma E., Eda K. Holl, Jeanne Jung, Junheng Gao, Sin-Ho Jung, Rami N. Al-Rohil, Maria A. Selim, et al. “Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.” Ann Surg Oncol 28, no. 7 (July 2021): 3501–10. https://doi.org/10.1245/s10434-020-09277-w.

Full Text

Farrow, Nellie E., Kristen E. Rhodin, and Georgia M. Beasley. “Nodal Recurrence as Primary Driver of Early Relapse in Patients with SLN-Positive Melanoma: What Does It Mean for Providers and Patients?” Annals of Surgical Oncology 28, no. 7 (July 2021): 3452–54. https://doi.org/10.1245/s10434-021-09806-1.

Full Text

DeVito, Nicholas C., Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K. S. Salama, Georgia M. Beasley, et al. “Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.” Cell Rep 35, no. 5 (May 4, 2021): 109071. https://doi.org/10.1016/j.celrep.2021.109071.

Full Text

Lee, Ann Y., Erica B. Friedman, James Sun, Aishwarya Potdar, Hala Daou, Norma E. Farrow, Clara R. Farley, et al. “Correction to: The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.” Ann Surg Oncol, April 23, 2021. https://doi.org/10.1245/s10434-021-10047-5.

Full Text

Straker, Richard J., Michael J. Carr, Andrew J. Sinnamon, Adrienne B. Shannon, James Sun, Karenia Landa, Kirsten M. Baecher, et al. “Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma.” Ann Surg Oncol, April 22, 2021. https://doi.org/10.1245/s10434-021-10031-z.

Full Text

Pages